Intraoperative dopamine release during globus pallidus internus stimulation in Parkinson's disease

Movement Disorders

Volumn 28, Issue 14, 2013, Pages 2027-2032

  Martinez, Raquel C R ^a,b   Hamani, Clement ^b   de Carvalho, Milene Cristina ^b   de Oliveira, Amanda Ribeiro ^b   Alho, Eduardo ^c   Navarro, Jessie ^b   dos Santos Ghilardi, Maria Gabriela ^b   Bor Seng Shu, Edson ^b   Heinsen, Helmut ^c   Otoch, José Pinhata ^b   Brandão, Marcus Lira ^b   Barbosa, Egberto Reis ^b   Teixeira, Manoel Jacobsen ^b   Fonoff, Erich Talamoni ^b  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Deep brain stimulation; Dopamine; Microdialysis; Motor symptoms; Parkinson's disease

Indexed keywords

DOPAMINE;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; BRAIN DEPTH STIMULATION; CASE REPORT; DOPAMINE RELEASE; FEMALE; GLOBUS PALLIDUS; GLOBUS PALLIDUS INTERNUS STIMULATION; HUMAN; INTRAOPERATIVE PERIOD; MALE; MICRODIALYSIS; MICROELECTRODEGUIDED PALLIDOTOMY; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; OPERATING ROOM; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL;

DEEP BRAIN STIMULATION; DOPAMINE; MICRODIALYSIS; MOTOR SYMPTOMS; PARKINSON'S DISEASE;

AGED; BIOPHYSICS; CHROMATOGRAPHY, LIQUID; DEEP BRAIN STIMULATION; DOPAMINE; FEMALE; GLOBUS PALLIDUS; HUMANS; INTRAOPERATIVE PERIOD; MALE; MICRODIALYSIS; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; TIME FACTORS;

EID: 84889638386     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25691     Document Type: Article

References (25)

1. Rodriguez-Oroz MC, Jahanshahi M, Krack P, et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol 2009;8:1128-1139).
2. Prensa L, Cossette M, Parent A. Dopaminergic innervation of human basal ganglia. J Chem Neuroanat 2000;20:207-213.
3. Jan C, François C, Tandé D, et al. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients. Eur J Neurosci 2000;12:4525-4535.
4. Sundström E, Fredriksson A, Archer T. Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease. Brain Res 1990;528:181-188.
5. Barrio JR, Huang SC, Phelps ME. Biological imaging and the molecular basis of dopaminergic diseases. Biochem Pharmacol 1997;54:341-348.
6. Rajput AH, Sitte HH, Rajput A, et al. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology 2008;70:1403-1410.
7. Fox SH, Katzenschlager R, Lim SY, et al. The Movement Disorder Society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease. Mov Disord 2011;26(Suppl 3):S2-S41.
8. Rodrigues JP, Walters SE, Watson P, et al. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease. Mov Disord 2007;22:1866-1870.
9. Fedele E, Stefani A, Bassi A, et al. Clinical and electrophysiological effects of apomorphine in Parkinson's disease patients are not paralleled by amino acid elease changes: a microdialysis study. Funct Neurol 2001;16:57-66.
10. Stefani A, Fedele E, Galati S, et al. Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients. Ann Neurol 2005;57:448-452.
11. Zsigmond P, Dernroth N, Kullman A, et al. Stereotactic microdialysis of the basal ganglia in Parkinson's disease. J Neurosci Methods 2012;207:17-22.
12. Darvesh AS, Carroll RT, Geldenhuys WJ, et al. In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opin Drug Discov 2011;6:109-127.
13. Fujiwara H, Fujii Y, Tanaka C. Labeled norepinephrine uptake and release in rat globus pallidus. Brain Res 1983;279:127-132.
14. Boix F, Sandor P, Nogueira PJ, et al. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience 1995;64:1045-1055.
15. Martinez RC, Oliveira AR, Macedo CE, et al. Involvement of dopaminergic mechanisms in the nucleus accumbens core and shell subregions in the expression of fear conditioning. Neurosci Lett 2008;446:112-116.
16. Bezard E, Dovero S, Prunier C, et al. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. J Neurosci 2001;21:6853-6861.
17. Mounayar S, Boulet S, Tandé D, et al. A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery. Brain 2007;130:2898-2914.
18. Kordower JH, Olanow CW, Dodiya HB, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 2013;136:2419-2431.
19. Vaillancourt DE, Prodoehl J, Verhagen Metman L, et al. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease. Brain 2004;127:491-504.
20. Hamani C, Temel Y. Deep brain stimulation for psychiatric disease: contributions and validity of animal models. Sci Transl Med 2012;4:142rv8.
21. Meissner W, Harnack D, Hoessle N, et al. High frequency stimulation of the entopeduncular nucleus has no effect on striatal dopaminergic transmission. Neurochem Int 2004;44:281-286.
22. Bruet N, Windels F, Bertrand A, et al. High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. J Neuropathol Exp Neurol 2001;60:15-24.
23. Lacombe E, Carcenac C, Boulet S, et al. High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3, 4-dihydroxyphenylalanine in dopaminergic denervated rats. Eur J Neurosci 2007;26:1670-1680.
24. Strafella AP, Sadikot AF, Dagher A. Subthalamic deep brain stimulation does not induce striatal dopamine release in Parkinson's disease. Neuroreport 2003;14:1287-1289.
25. Abosch A, Kapur S, Lang AE, et al. Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery 2003;53:1095-1105.